[HTML][HTML] Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
Y Haruyama, H Kataoka - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Abstract Glypican-3 (GPC3) is a cell surface oncofetal proteoglycan that is anchored by
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
[引用][C] Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
Y Haruyama - World Journal of Gastroenterology, 2016 - cir.nii.ac.jp
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular
carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[HTML][HTML] Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
Y Haruyama, H Kataoka - World Journal of Gastroenterology, 2016 - wjgnet.com
Abstract Glypican-3 (GPC3) is a cell surface oncofetal proteoglycan that is anchored by
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma.
Y Haruyama, H Kataoka - World Journal of Gastroenterology, 2016 - europepmc.org
Abstract Glypican-3 (GPC3) is a cell surface oncofetal proteoglycan that is anchored by
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
[PDF][PDF] Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
Y Haruyama, H Kataoka - World J Gastroenterol, 2016 - pdfs.semanticscholar.org
Abstract Glypican-3 (GPC3) is a cell surface oncofetal proteoglycan that is anchored by
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
Y Haruyama, H Kataoka - World journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Glypican-3 (GPC3) is a cell surface oncofetal proteoglycan that is anchored by
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
Y Haruyama, H Kataoka - World Journal of Gastroenterology, 2016 - wjgnet.com
Figure 1 A schematic drawing of the structure of the glypican-3 molecule. The core protein
consists of 580 amino acids, and two heparan sulfate (HS) side chains are attached close to …
consists of 580 amino acids, and two heparan sulfate (HS) side chains are attached close to …
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma.
Y Haruyama, H Kataoka - World Journal of Gastroenterology, 2016 - europepmc.org
Abstract Glypican-3 (GPC3) is a cell surface oncofetal proteoglycan that is anchored by
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …
glycosylphosphatidylinositol. Whereas GPC3 is abundant in fetal liver, its expression is …